SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-008444
Filing Date
2022-05-12
Accepted
2022-05-12 07:53:13
Documents
64
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q akus-20220331x10q.htm   iXBRL 10-Q 1624563
2 EX-10.1 akus-20220331xex10d1.htm EX-10.1 20871
3 EX-31.1 akus-20220331xex31d1.htm EX-31.1 16820
4 EX-31.2 akus-20220331xex31d2.htm EX-31.2 16813
5 EX-32.1 akus-20220331xex32d1.htm EX-32.1 13496
  Complete submission text file 0001558370-22-008444.txt   6050443

Data Files

Seq Description Document Type Size
6 EX-101.SCH akus-20220331.xsd EX-101.SCH 35738
7 EX-101.CAL akus-20220331_cal.xml EX-101.CAL 44773
8 EX-101.DEF akus-20220331_def.xml EX-101.DEF 129915
9 EX-101.LAB akus-20220331_lab.xml EX-101.LAB 359361
10 EX-101.PRE akus-20220331_pre.xml EX-101.PRE 269339
58 EXTRACTED XBRL INSTANCE DOCUMENT akus-20220331x10q_htm.xml XML 1004844
Mailing Address 645 SUMMER STREET, SUITE 200 BOSTON MA 02210
Business Address 645 SUMMER STREET, SUITE 200 BOSTON MA 02210 857-410-1818
Akouos, Inc. (Filer) CIK: 0001722271 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39343 | Film No.: 22915761
SIC: 2834 Pharmaceutical Preparations